These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34343506)

  • 1. Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use.
    Rosenthal J; Howell M; Earl V; Malik M
    Am J Med; 2021 Dec; 134(12):e582-e583. PubMed ID: 34343506
    [No Abstract]   [Full Text] [Related]  

  • 2. Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome.
    Witsil JC; Mycyk MB
    Am J Ther; 2017; 24(1):e64-e67. PubMed ID: 25393073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older: A Systematic Review and Metaregression Analysis.
    Velayudhan L; McGoohan KL; Bhattacharyya S
    JAMA Netw Open; 2021 Feb; 4(2):e2035913. PubMed ID: 33528550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
    Hickey JL; Witsil JC; Mycyk MB
    Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
    Inayat F; Virk HU; Ullah W; Hussain Q
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28052951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic cannabinoid leading to cannabinoid hyperemesis syndrome.
    Bick BL; Szostek JH; Mangan TF
    Mayo Clin Proc; 2014 Aug; 89(8):1168-9. PubMed ID: 25092369
    [No Abstract]   [Full Text] [Related]  

  • 7. Cannabinoid hyperemesis syndrome.
    Galli JA; Sawaya RA; Friedenberg FK
    Curr Drug Abuse Rev; 2011 Dec; 4(4):241-9. PubMed ID: 22150623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.
    Richards JR; Lapoint JM; Burillo-Putze G
    Clin Toxicol (Phila); 2018 Jan; 56(1):15-24. PubMed ID: 28730896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
    Jones SE; Durant JR; Greco FA; Robertone A
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():45-8. PubMed ID: 6299555
    [No Abstract]   [Full Text] [Related]  

  • 10. Cannabinoid hyperemesis syndrome: a guide for the practising clinician.
    Bajgoric S; Samra K; Chandrapalan S; Gautam N
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26698198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical capsaicin cream in the treatment for cannabinoid hyperemesis syndrome].
    Román F; Llorens P; Burillo-Putze G
    Med Clin (Barc); 2016 Dec; 147(11):517-518. PubMed ID: 27751515
    [No Abstract]   [Full Text] [Related]  

  • 12. Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
    Levitt M
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():49-53. PubMed ID: 6299556
    [No Abstract]   [Full Text] [Related]  

  • 13. Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva).
    Darmani NA; Chebolu S; Zhong W; Trinh C; McClanahan B; Brar RS
    Eur J Pharmacol; 2014 Jan; 722():147-55. PubMed ID: 24157976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.
    Einhorn L
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():55-61. PubMed ID: 6299557
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative trial of the antiemetic effects of THC and haloperidol.
    Neidhart JA; Gagen MM; Wilson HE; Young DC
    J Clin Pharmacol; 1981; 21(S1):38S-42S. PubMed ID: 6271838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).
    Mersiades AJ; Tognela A; Haber PS; Stockler M; Lintzeris N; Simes J; McGregor I; Olver I; Allsop DJ; Gedye C; Kirby AC; Morton RL; Fox P; Clarke S; Briscoe K; Aghmesheh M; Wong N; Walsh A; Hahn C; Grimison P
    BMJ Open; 2018 Sep; 8(9):e020745. PubMed ID: 30209152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis-based medicinal products: summary of NICE guidance.
    Chang-Douglass S; Mulvihill C; Pilling S;
    BMJ; 2020 Apr; 369():m1108. PubMed ID: 32317246
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of the stress response and the endocannabinoid system in Δ
    DeVuono MV; La Caprara O; Sullivan MT; Bath A; Petrie GN; Limebeer CL; Rock EM; Hill MN; Parker LA
    Psychopharmacology (Berl); 2020 Jul; 237(7):2187-2199. PubMed ID: 32399633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.
    Rock EM; Kopstick RL; Limebeer CL; Parker LA
    Br J Pharmacol; 2013 Oct; 170(3):641-8. PubMed ID: 23889598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dronabinol and nabilone ease cancer chemotherapy.
    Manzo M
    Nursing; 1988 Aug; 18(8):81. PubMed ID: 2839807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.